ADAPTIMMUNE THERAPEUTICS PLC
Cash Flow Statement
| Line Item | FY2016 | FY2015 | FY2014 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-71.6M | $-22.1M | $-11.6M |
| Depreciation & Amortization | — | — | — |
| Depreciation | $3.1M | $705.0K | $240.0K |
| Amortization | $160.0K | $30.0K | $0 |
| Stock-Based Compensation | $8.8M | $7.1M | $332.0K |
| Net Cash from Operating Activities | $-48.2M | $-29.7M | $36.8M |
| Investing Activities | |||
| Capital Expenditures | $11.5M | $5.1M | $1.4M |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $17.8M | $-58.8M | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $17.0K | $274.9M | — |
| Net Change in Cash | $-36.0M | $177.9M | — |
| Free Cash Flow | $-59.7M | $-34.7M | $35.5M |